<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Research in Molecular Medicine</title>
<title_fa>Research in Molecular Medicine</title_fa>
<short_title>Res Mol Med (RMM)</short_title>
<subject>Medical Sciences</subject>
<web_url>http://rmm.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1348</journal_id_issn>
<journal_id_issn_online>2322-133X</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/rmm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Optimization of Culture Condition for the Production of Menaquinone-7 by Bacillus Subtilis Natto</title>
	<subject_fa>بیوتکنولوژی</subject_fa>
	<subject>Biotechnology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Vitamin K2 refers to a series of naphthoquinone derivatives, which have a variety of physiological and pharmacological functions for the human body. The most important type of vitamin K2 is menaquinone-7 (MK-7), an expensive raw material with no local manufacturers in Iran.&lt;br&gt;
&lt;strong&gt;Objectives:&lt;/strong&gt; Since there was no report on the yield of MK-7 produced by the currently available Bacillus subtilis natto species in Iran, this study aims to optimize the culture condition for the production of MK-7 using this Bacillus species.&lt;/div&gt;

&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Materials and Methods: &lt;/strong&gt;The base medium (BM) for MK-7 production contained glycerol (6.3%), soybean peptone (3%), and yeast extract (0.51%). The selected factors for optimizing the MK-7 production included the incubation temperature (30, 37, and 40&amp;deg;C) and incubation time (72, 96, and 120hr) with/without the addition of K2HPO4 to the fermentation medium. Three sets of experiments with six modes in each set were designed based on these parameters. MK-7 content was analyzed by the HPLC method.&lt;br&gt;
&lt;strong&gt;Results: &lt;/strong&gt;Two experiments showed the highest MK-7 production yields of 0.319 and 0.3158 mg/L. The culture condition for both of these yields was as follows:120 hours incubation time in the presence of K2HPO4. However, the incubation temperature was different in these two experiments. The incubation temperature of 30&amp;deg;C resulted in 0.319 mg/L MK-7 concentration, and 37&amp;deg;C yielded 0.3158 mg/L.&lt;br&gt;
&lt;strong&gt;Conclusion: &lt;/strong&gt;&lt;em&gt;B. subtilis&lt;/em&gt; natto (IBRC-M 11153) is suitable to be used as a basic platform for the mutation and production of a high-producer species. Optimizing the culture conditions using the wild-type species is not beneficial in increasing the production ability of the bacterium. It is necessary to use different methods for enhancing the production yield of MK-7 to lower the cost of microbial production and make the industrial process economic.&lt;br&gt;
&amp;nbsp;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Vitamin K2, Bacillus subtilis natto, Menaquinone-7, fermentation</keyword>
	<start_page>37</start_page>
	<end_page>46</end_page>
	<web_url>http://rmm.mazums.ac.ir/browse.php?a_code=A-10-1239-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mohammad</first_name>
	<middle_name></middle_name>
	<last_name>Sharifzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>msharifzadeh@tums.ac.ir</email>
	<code>100319475328460010563</code>
	<orcid>100319475328460010563</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Negar</first_name>
	<middle_name></middle_name>
	<last_name>Mottaghi-Dastjerdi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mottaghi.n@iums.ac.ir</email>
	<code>100319475328460010564</code>
	<orcid>100319475328460010564</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad</first_name>
	<middle_name></middle_name>
	<last_name>Soltany-Rezaee-Rad</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mohammad.soltany@gmail.com</email>
	<code>100319475328460010565</code>
	<orcid>100319475328460010565</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmaceutical Biotechnology and Pharmaceutical Biotechnology Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Marjan</first_name>
	<middle_name></middle_name>
	<last_name>Shariatpanahi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shariatpanahi.m@iums.ac.ir</email>
	<code>100319475328460010566</code>
	<orcid>100319475328460010566</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Israa</first_name>
	<middle_name></middle_name>
	<last_name>Khalid AL-Yasari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>asoangel31@gmail.com</email>
	<code>100319475328460010567</code>
	<orcid>100319475328460010567</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Sara</first_name>
	<middle_name></middle_name>
	<last_name>Noroozi Eshlaghi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460010568</code>
	<orcid>100319475328460010568</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. Department of Chemistry, Faculty of Science, University of Zanjan, Zanjan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
